Covidien, a medical device company, said Tuesday that it posted net profit of $56 million, or 11 cents a share, for the fiscal fourth quarter ended Sept. 25, compared with $409 million, or 84 cents a share, a year earlier. Net results were reduced by a variety of charges related to various divestitures and acquisitions.
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter
Advertisement